news aktuell GmbH

X-Technology moves into the future with strong new leadership

5.4.2022 10:26:37 CEST | news aktuell GmbH | Pressemelding

Del
X-Technology Swiss research & development AG based in Wollerau, is moving into the future with a new management team after a change of ownership. Over the past few decades, the company has established some real cult brands in the field of performance sportswear with its X-Bionic and X-Socks labels. This market position is now being expanded globally under the leadership of CEO Maximilian Lenk. Lenk is also bring on board a very entrepreneurial, innovative and clearly digitally-minded team of managers. At the same time, the sales organization is being realigned.
Maximilian Lenk, CEO, X-Technology Swiss research & development AG
Maximilian Lenk, CEO, X-Technology Swiss research & development AG

(Wollerau, Switzerland): X-Technology, with its brands X-Bionic and X-Socks, has become one of the leading suppliers of textile performance technologies. The X-Bionic brand has won the Plus X Award, the world's largest innovation prize for technology, sport and lifestyle, as the most innovative brand of the year 13 times in a row. In total, X-Technology has over 800 international patent applications to its credit and has won over 600 awards and more than 1,200 medals at international championships and Olympiads. The patented technologies enable athletes achieve top performance in all conditions and to train longer, safer and more comfortably.

The new management team is composed as follows.

Maximilian Lenk, CEO, worked for the Mammut Sports Group for 10 years - most recently as Chief Product Officer. During his time there, he contributed significantly to the strategic realignment and digitization of the brand. (Start: April 1, 2022)

Jana Hildenbrand, CFO, was most recently Director Corporate Controlling & Indirect Procurement at Marc O'Polo. Jana was instrumental in the strong growth of the brand for over 20 years. (Start: February 1, 2022)

Patrick Strumpf, CCO (Chief Commercial Officer), has successfully founded and managed several commercial companies. He was most recently a member of the Executive Board at Brack.ch, where he built up the Home&Living division as well as the own brands area. (Start: May 1, 2022)

Martijn Jegerings, Chief Marketing Officer, was most recently Head of Brand Strategy & Data Intelligence at Mammut Sports Group. He was jointly responsible for the very successful digitization of the Mammut brand and is co-founder of the outdoor sportswear company Open Wear. (Start: May 1, 2022)

The sales organization will be under new management as follows from June 1, 2022:

Urs Rüttimann, Head of Sales German Speaking Countries, has worked for Adidas for almost 24 years, most recently as Director Key Account Switzerland & Austria and member of the Executive Board of adidas sport gmbh.

Christian Härig, Head of Sales Corporate Business/Special Projects, was most recently Market Manager Switzerland at BMC Switzerland. Before this, he worked for the Mammut Sports Group for 10 years - most recently as Head of Corporate Business.

Steffen Pabst, Head of Global Sales, joined X-Bionic in April 2019 as Commercial Director. He previously worked as Sales Manager at Odlo, Operations Director at Starbucks and Director of Stores at Nike.

"We as a team share the enthusiasm for this exceptional company, our strong brands and the market potential. I'm really looking forward to working with my team to develop our technologies, our products and our community; to deliver exceptional products and experiences to our customers. We are taking the next big step to support the countless sports enthusiasts in their passion with our performance wear," says Maximilian Lenk.

Kontakter

Karin Lehmann
WeArePepper GmbH
karin@wearepepper.ch

Bilder

Maximilian Lenk, CEO, X-Technology Swiss research & development AG
Maximilian Lenk, CEO, X-Technology Swiss research & development AG
Last ned bilde

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Slovak outlet Denník N republishes numerous false allegations about Alisher Usmanov that courts have already held to be unlawful13.3.2026 08:48:33 CET | Press release

(Hamburg, Germany - 12 March 2026) On 11 March 2026, the Slovak news outlet Denník N published an article concerning the alleged efforts of the Slovak government to secure the removal of two Russian nationals from the EU sanctions list. The article contained an extensive passage concerning our client, Mr Alisher Burkhanovich Usmanov. By letter dated 12 March 2026, Denník N was requested, in order to avoid court proceedings, to provide a cease-and-desist undertaking backed by a contractual penalty. “The article was published on the eve of the European Commission’s decision on the extension of the sanctions. It reads as if its authors had taken particular care to assemble, in a single piece, every factual allegation that courts have previously found to be unlawful,” said Mr Usmanov’s lawyer, Joachim Nikolaus Steinhöfel. The article contained a dozen such statements about Alisher Usmanov, even though these very allegations have for years been prohibited, retracted, deleted or corrected in

Ship parades, evening shows and partner region Liverpool The 837th HAMBURG PORT ANNIVERSARY with a top programme11.3.2026 14:02:16 CET | Press release

(Hamburg, 11 March 2026) From 8 to 10 May 2026, Hamburg is celebrating its 837th HAMBURG PORT ANNIVERSARY. The programme includes traditional highlights such as the arrival and departure parades and the unique tugboat ballet, as well as several evening shows and the fascinating fireworks display. The programme will be supplemented by new events on the water and on land. The Big Arrival Parade on Friday, 8 May, at 1:30 p.m. marks the start of the festivities and is always an unforgettable experience: more than 100 impressive ships sail up the Elbe right before the eyes of the spectators. The majestic tall ship, the Norwegian three-masted barque Statsraad Lehmkuhl, is particularly stunning. The floating Elbe stage in front of the Landungsbrücken is THE artistic anchor of the HAMBURG PORT ANNIVERSARY: Elbe in Concert presents visitors with rousing live music and impressive performances, creating a unique atmosphere against the backdrop of the harbour skyline at night. This year’s partner

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye